Publication:
Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome

dc.contributor.authorArıkan, Çiğdem
dc.contributor.authorKılıç, Murat
dc.contributor.authorNart, Deniz
dc.contributor.authorÖzgenç, Funda
dc.contributor.authorTokat, Yaman
dc.contributor.authorYağcı, Raşit V.
dc.contributor.authorAydoğdu, Sema
dc.contributor.buuauthorÖzkan, Tuğba
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPediatrik Gastroenteroloji, Hepatoloji ve Beslenme Ana Bilim Dalı
dc.contributor.scopusid7004474005
dc.date.accessioned2021-09-10T11:24:06Z
dc.date.available2021-09-10T11:24:06Z
dc.date.issued2006
dc.description.abstractHepatocellular carcinoma (HCC) is primarily observed in the older children and in most cases it develops in association with liver cirrhosis. Liver transplantation offers a good chance for long-term cure. To evaluate the outcome of children with HCC and the impact of living-donor orthotopic liver transplantation (OLT) on survival a retrospective review of radiographic, laboratory, pathologic, and therapeutic data in 13 children (six female and seven male) with chronic liver disease accompanied with HCC were studied. The patients were divided into two groups according to therapeutic modality: transplanted and non-transplanted patients. Kaplan-Meier survival curves in various therapeutic groups were plotted. The mean age of patients was 6.4 +/- 4.8 yr. Pediatric end-stage liver disease score was adapted to model for end-stage liver disease score for HCC and ranged between 1-44 and 18-44, respectively. The underlying liver diseases were tyrosinemia type 1 (n = 6), chronic hepatitis B infection (n equals;6), glycogen storage disease type 1 (n = 1). Alfa-feto protein levels were elevated in all patients except one. Median number of tumor nodules was three (1-10), median maximal diameter of tumor nodules was 3.4 cm (0.5-8). Eleven patients were eligible for OLT whereas two patients were not eligible. Seven of the 11 patients considered for transplantation underwent living-donor OLT. Remaining four patients died while waiting on cadaveric transplant list. Overall 1 and 4-yr survival rates for all patients were 53.3 and 26.6%, respectively, and were found significantly higher in transplanted children than non-transplanted children (72%, 72% vs. 33% and 16.6%). No patient had tumor recurrence at median of 36-month follow-up after OLT. OLT is a life-saving procedure for children with chronic liver disease accompanying with HCC. Living-donor OLT avoids the risk of tumor progression and transplant ineligibility in these children.
dc.identifier.citationArıkan, C. vd. (2006). ''Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome''. Pediatric Transplantation, 10(1), 42-47.
dc.identifier.endpage47
dc.identifier.issn1397-3142
dc.identifier.issn1399-3046
dc.identifier.issue1
dc.identifier.pubmed16499586
dc.identifier.scopus2-s2.0-33645989454
dc.identifier.startpage42
dc.identifier.urihttps://doi.org/10.1111/j.1399-3046.2005.00395.x
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/j.1399-3046.2005.00395.x
dc.identifier.urihttp://hdl.handle.net/11452/21855
dc.identifier.volume10
dc.identifier.wos000235371400008
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherWiley
dc.relation.collaborationYurt içi
dc.relation.journalPediatric Transplantation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPediatrics
dc.subjectTransplantation
dc.subjectSurvival
dc.subjectPediatric liver transplantation
dc.subjectPediatric end-stage liver disease score
dc.subjectModel for end-stage liver disease score for hepatocellular carcinoma
dc.subjectChronic liver disease
dc.subjectHepatocellular carcinoma
dc.subjectTumors
dc.subjectCriteria
dc.subjectSurvival
dc.subjectCirrhosis
dc.subjectInfection
dc.subjectHepatoblastoma
dc.subjectChildhood
dc.subjectNatural-history
dc.subject.scopusHepatoblastoma; Liver Neoplasms; Metastasectomy
dc.subject.wosPediatrics
dc.subject.wosTransplantation
dc.titleHepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome
dc.typeArticle
dc.wos.quartileQ3 (Transplantation)
dc.wos.quartileQ2 (Pediatrics)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Pediatrik Gastroenteroloji, Hepatoloji ve Beslenme Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: